Japanese scientists develop a new device for metronomic photodynamic therapy to facilitate a minimally-invasive and effective cancer treatment in delicate organs
Scientists from Waseda University, the National Defense Medical College, and the Japan Science and Technology Agency developed a new bioadhesive, wirelessly-powered light-emitting device which could better treat cancers in delicate organs.
Conventional photodynamic therapy induces cancer cell death by using photosensitizing agents, which localize in tumors and activate with exposure to a specific wavelength of light. In recent years, low-dose and long-term photodynamic therapy (metronomic photodynamic therapy, mPDT) has shown promise in treating cancers in internal organs. The problem with mPDT is, however, is that because the light intensity is extremely low (1/1000 of the conventional method), the antitumor effect cannot be obtained if the light source shifts even slightly away from the tumor, making the illumination insufficient.
“To address this issue, we have developed a wirelessly-powered optoelectronic device that stably fixes itself onto the inner surface of an animal tissue like a sticker with bioadhesive and elastic nanosheets, enabling a continuous, local light delivery to the tumor,” says Toshinori Fujie, associate professor of biomedical engineering at Waseda University. The nanosheets are modified with the mussel adhesive protein-inspired polymer polydopamine, which can stabilize the device onto a wet animal tissue for more than 2 weeks without surgical suturing or medical glue. The light-emitting diode chips in the device are wirelessly powered by near-field-communication technology.
To test its effectiveness, tumor-bearing mice implanted with the device were injected with a photosensitizing agent (photofrin) and exposed to red and green light, approximately 1,000-fold intensity lower than the conventional PDT approaches, for 10 consecutive days. The experiment showed that the tumor growth was significantly reduced overall. Especially under green light, the tumor in some mice was completely eradicated.
Associate Professor Fujie points out, “This device may facilitate treatment for hard-to-detect microtumors and deeply located lesions that are hard to reach with standard phototherapy, without having to worry about the risk of damaging healthy tissues by overheating. Furthermore, because the device does not require surgical suturing, it is suitable for treating cancer near major nerves and blood vessels, as well as for organs that are fragile, that change their shape, or that actively move, such as the brain, liver, and pancreas.”
If clinically applied, the device could be beneficial for cancer patients who seek minimally invasive treatment, helping them live longer and improve their quality of life.
Receive an email update when we add a new PHOTODYNAMIC THERAPY article.
The Latest on: Photodynamic therapy
via Google News
The Latest on: Photodynamic therapy
- MDACC 2018: Debate: Focal Therapy for Prostate Cancer on November 10, 2018 at 2:19 pm
The current landscape of focal therapy includes high-frequency focused ultrasound (HIFU), cryoablation, laser ablation, and vascular-targeted photodynamic therapy. Dr. Miles acknowledges that strong e... […]
- Soligenix Announces Recent Accomplishments And Third Quarter 2018 Financial Results on November 9, 2018 at 2:00 am
Our BioTherapeutics business segment is developing SGX301 as a novel photodynamic therapy utilizing safe visible light for the treatment of cutaneous T-cell lymphoma, our first-in-class innate defense ... […]
- Age-Related Macular Degeneration market 2018- applications, challenges, growth, shares, trends, top players and forecast to 2023 on November 1, 2018 at 7:28 am
Visudyne, photodynamic therapy (PDT), is used in a minority of patients usually combined with an anti-VEGF. The AMD pipeline has two longer-acting anti-VEGF drugs (Novartis/Alcon's brolucizumab ... […]
- UC researcher fighting breast cancer with light therapy on October 17, 2018 at 7:18 am
"Therapies such as photodynamic therapy (PDT), involving light and a photosensitizing chemical substance, which used in conjunction with molecular oxygen can cause cell death, offer a high degree of c... […]
- Swissmedic approves Ameluz® in combination with daylight photodynamic therapy in Switzerland on September 30, 2018 at 5:00 pm
Leverkusen, Germany, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F), an international biopharmaceutical company, announced today that Swissmedic, the Sw... […]
- Biofrontera uses the long summer months to introduce daylight photodynamic therapy (PDT) with Ameluz® in the EU on September 17, 2018 at 2:55 am
Leverkusen, Germany, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F), an international biopharmaceutical company, today announced an update on prelimina... […]
- Photofrin photodynamic therapy for treatment of AIDS-related cutaneous Kaposi‚s sarcoma on September 9, 2018 at 5:00 pm
Objective: Kaposi‚s sarcoma, the most common malignancy in AIDS patients, often presents with painful cutaneous lesions that are difficult to treat effectively despite a wide variety of therapeutic ap... […]
- Norfolk charity to close down on August 13, 2018 at 1:41 am
This project is aimed at using photodynamic therapy for the detection and treatment of lung cancer, and good progress has already been made. “The trustees and committee members would like to take this ... […]
- Photodynamic Therapy of Vulvar Lichen Sclerosus With 5-Aminolevulinic Acid on May 7, 2018 at 7:37 am
Objective To evaluate the therapeutic effect of photodynamic therapy on vulvar lichen sclerosus. Results Two women underwent two cycles of photodynamic therapy, one underwent three cycles, and the rem... […]
via Bing News